SavedAdd your journal

Journals / Turkish Journal of Obstetrics and Gynecology / 2018 / Cilt: 15 - Sayı: 1

Is the measurement of the size of uterine lesions with positron emission tomography consistent in pre- and postmenopausal periods in endometrioid-type endometrial cancer?

Endometrioid tip endometriyal kanserde, pre- ve postmenopozal dönemlerde pozitron emisyon tomografisi ile uterin lezyon boyutunun ölçümleri tutarlı mıdır?

Muzaffer SANCI
Mustafa KOCAER
Kemal GÜNGÖRDÜK
Varol GÜLSEREN
Özgü ÇELİKKOL GÜNGÖRDÜK
İsa Aykut ÖZDEMİR
Pages
60–64
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, there was a correlation in postmenopausal women (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: We aimed to investigate the correlation of the size and volume of uterine tumors obtained using positron emission tomography/computedtomography (PET/CT) and pathology specimens in patients with endometrioid-type endometrial cancer (EEC) in the premenopausal period, and tocompare the results with those of postmenopausal women.
📊
Key Findings & Data:The thickness and volume of the uterine lesion, and its maximumstandardized uptake value as obtained using PET/CT and hysterectomy pathology specimens were recorded.Results: Tumor size (p=0.051) and volume (p=0.404) were not found to be correlated with the imaging method used in premenopausal women andpathologic specimens.
💡
Conclusion & Impact:However, there was a correlation in postmenopausal women (p
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: We aimed to investigate the correlation of the size and volume of uterine tumors obtained using positron emission tomography/computedtomography (PET/CT) and pathology specimens in patients with endometrioid-type endometrial cancer (EEC) in the premenopausal period, and tocompare the results with those of postmenopausal women. In the premenopausal period, the endometrium uses more glucose than in the postmenopausalperiod. Therefore, the measurement of uterine tumor size using PET/CT in the premenopausal period may normally be different.Materials and Methods: In this retrospective study, we reviewed the records of patients who were diagnosed as having EEC and underwent hysterectomy.Only patients who underwent preoperative PET/CT imaging were included in the study. The thickness and volume of the uterine lesion, and its maximumstandardized uptake value as obtained using PET/CT and hysterectomy pathology specimens were recorded.Results: Tumor size (p=0.051) and volume (p=0.404) were not found to be correlated with the imaging method used in premenopausal women andpathologic specimens. However, there was a correlation in postmenopausal women (p

Özet

Amaç: Endometrioid tip endometriyum kanseri (EEK) olan hastalarda pozitron emisyon tomografisi/bilgisayarlı tomografi (PET/BT) ve patoloji örnekleri ile elde edilen uterin tümörlerin boyut ve hacimlerinin korelasyonunu ve premenopozal dönem ile postmenopozal kadınların sonuçlarını karşılaştırmayı amaçladık. Premenopoz dönemlerde, endometriyum, postmenopozal dönemlere kıyasla daha fazla glukoz kullanır. Bu nedenle, premenopozal dönemde uterin tümör büyüklüğünün PET/BT ile ölçümü normalden farklı olabilir. Gereç ve Yöntemler: Bu retrospektif çalışmada EEK tanısı alan ve histerektomi yapılan hastaların kayıtları gözden geçirildi. Sadece preoperatif PET/ BT görüntüleme yapılan hastalar çalışma kapsamına alındı. Uterin lezyonun kalınlığı, hacmi ve maksimum standartlaştırılmış alım değerleri PET/BT ve histerektomi patoloji örnekleri tarafından elde edilen veriler kaydedildi. Bulgular: Premenopozal çağdaki kadınlarda tümör boyutu (p=0,051) ve hacmi (p=0,404) görüntüleme yöntemi ve patolojik örnekler arasında korelasyon bulunamadı. Bununla birlikte, postmenopozal kadınlarda bir korelasyon vardı (p

🔖

Cite This Article

SANCI, M., KOCAER, M., GÜNGÖRDÜK, K., GÜLSEREN, V., GÜNGÖRDÜK, Ö. Ç., ÖZDEMİR, İ. A. (2022). Is the measurement of the size of uterine lesions with positron emission tomography consistent in pre- and postmenopausal periods in endometrioid-type endometrial cancer?. Turkish Journal of Obstetrics and Gynecology, Cilt: 15 - Sayı: 1, 60–64. https://ajindex.com/articles/613050

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I. Endometrial cancer. Lancet 2005;366:491-505.
  2. Özgü E, Öz M, Yıldız Y, Özgü BS, Erkaya S, Güngör T. Prognostic value of 18F-FDG PET/CT for identifying high- and low-risk endometrial cancer patients. Ginekol Pol 2016;87:493-7.
  3. Nakamura K, Kodama J, Okumura Y, Hongo A, Kanazawa S, Hiramatsu Y. The SUVmax of 18F-FDG PET Correlates With Histological Grade in Endometrial Cancer. Int J Gynecol Cancer 2010;20:110-5.
  4. Croteau E, Renaud JM, Richard MA, Ruddy TD, Bénard F, deKemp RA. PET Metabolic Biomarkers for Cancer. Biomark Cancer 2016;8(Suppl 2):61-9.
  5. Boonya-ussadorn T, Choi WH, Hyun OJ, Kim SH, Chung SK, Yoo R. 18F-FDG PET/CT Findings in Endometrial Cancer Patients: The Correlation between SUVmax and Clinicopathologic Features. J Med Assoc Thai 2014;97:S115-22. Chander S, Meltzer CC, McCook BM. Physiologic uterine uptake of FDG during menstruation demonstrated with serial combined positron emission tomography and computed tomography. Clin Nucl Med 2002;27:22-4.
  6. Lerman H, Metser U, Grisaru D, Fishman A, Lievshitz G, EvenSapir E. Normal and Abnormal 18F-FDG Endometrial and Ovarian Uptake in Pre- and Postmenopausal Patients: Assessment by PET/CT. J Nucl Med 2004;45:266–71
  7. Haldorsen IS, Salvesen HB. What Is the Best Preoperative Imaging for Endometrial Cancer? Curr Oncol Rep 2016;18:25. Nogami Y, Banno K, Irie H, Iida M, Kisu I, Masugi Y, et al. The efficacy of preoperative PET-CT for detection of lymph node metastasis in cervical and endometrial cancer: clinical and pathological factors influencing it. Jpn J Clin Oncol 2015;45:26-34.
  8. Ghooshkhanei H, Treglia G, Sabouri G, Davoodi R, Sadeghi R. Risk stratification and prognosis determination using (18)F-FDG PET imaging in endometrial cancer patients: a systematic review and meta-analysis. Gynecol Oncol 2014;132:669-76.
  9. Boonya-ussadorn T, Choi WH, Hyun J, Kim SH, Chung SK, Yoo IeR. 18F-FDG PET/CT findings in endometrial cancer patients: the correlation between SUVmax and clinicopathologic features. J Med Assoc Thai 2014;97 (Suppl 2):S115-22. Kakhki VR, Shahriari S, Treglia G, Hasanzadeh M, Zakavi SR, Yousefi Z, et al. Diagnostic Performance of Fluorine 18 FDG PET Imaging for Detection of Primary Lesion and Staging of Endometrial Cancer Patients Systematic Review and Meta-Analysis of the Literature. Int J Gynecol Cancer 2013;23:1536-43.
  10. Kitajima K, Murakami K, Yamasaki E, Kaji Y, Sugimura K. Accuracy of integrated FDG-PET/contrast-enhanced CT in detec